1 |
Ni R, Feng R, Chau Y. Peptide-DNA Co-Assembled Nanoparticles as a Nonviral Vector for Gene Delivery with High Transgene Expression. ACS Appl Nano Mater 2023. [DOI: 10.1021/acsanm.2c04279] [Reference Citation Analysis]
|
2 |
Ferretti GDS, Quarti J, dos Santos G, Rangel LP, Silva JL. Anticancer Therapeutic Strategies Targeting p53 Aggregation. IJMS 2022;23:11023. [DOI: 10.3390/ijms231911023] [Reference Citation Analysis]
|
3 |
Sharapov MG, Goncharov RG, Parfenyuk SB, Glushkova OV. Effect of Peroxiredoxin 6 on p53 Transcription Factor Level. Biochemistry Moscow 2022;87:839-849. [DOI: 10.1134/s0006297922080156] [Reference Citation Analysis]
|
4 |
Rocca V, Blandino G, D’antona L, Iuliano R, Di Agostino S. Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment. Cancers 2022;14:3664. [DOI: 10.3390/cancers14153664] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Arshad F, Nabi F, Iqbal S, Khan RH. Applications of graphene-based electrochemical and optical biosensors in early detection of cancer biomarkers. Colloids Surf B Biointerfaces 2022;212:112356. [PMID: 35123193 DOI: 10.1016/j.colsurfb.2022.112356] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
|
6 |
Ostrowski RP, Pucko EB. Harnessing oxidative stress for anti-glioma therapy. Neurochem Int 2022;:105281. [PMID: 35038460 DOI: 10.1016/j.neuint.2022.105281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|